E-posters 14th Morning – Station 1

       
TITLE E-POSTER REFERENCE START TIME END TIME  
SHOTGUN METAGENOMICS, 16S RRNA GENE SEQUENCING, AND HUMAN GENETICS DIFFERENTIALLY CLASSIFY PAEDIATRIC CROHN’S DISEASE STATE AND TREATMENT OUTCOME EP01 13:00 13:05 1
CHARACTERIZATION OF THE T CELL RECEPTOR REPERTOIRE IN PEDIATRIC ULCERATIVE COLITIS EP02 13:05 13:10 2
AGE-OF-ONSET DEPENDENT ILEAL IMMUNE MATURATION AND REDUCED ALPHA-DEFENSIN EXPRESSION IN PEDIATRIC CROHN DISEASE DESPITE STABLE DYSBIOSIS EP03 13:10 13:15 3
VARIABILITY OF CORE MICROBIOTA IN NEWLY DIAGNOSED TREATMENT-NAÏVE PAEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS EP04 13:15 13:20 4
HISTOPATHOLOGICAL QUANTITATIVE ANALYSIS OF CD30+ LYMPHOCYTES IN BOWEL MUCOSA CAN IMPROVE DIFFERENTIAL DIAGNOSIS OF PEDIATRIC CROHN’S DISEASE AND ULCERATIVE COLITIS EP05 13:20 13:25 5
USE OF IGG-BINDING AS A MARKER OF BACTERIAL VIRULENCE IN THE TERMINAL ILEUM OF PEDIATRIC IBD PATIENTS EP06 13:25 13:30 6
INNATE LYMPHOID CELLS IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE EP07 13:30 13:35 7
CORRELATION BETWEEN GUT ENVIRONMENT AND BACTERIAL INVASION IN PEDIATRIC INFLAMMATORY BOWEL DISEASES EP08 13:35 13:40 8
INFLAMMASOME ACTIVATION IN MACROPHAGES PROMOTES EPITHELIAL CELL RECOVERY DURING CITROBACTER RODENTIUM INFECTION EP09 13:40 13:45 9
SEVERE LYMPHONODULAR HYPERPLASIA AND IBD-LIKE PHENOTYPE DUE TO AN ACTIVATING PIK3CD MUTATION EP10 13:45 13:50 10

E-posters 14th Morning – Station 2

TITLE E-POSTER REFERENCE START TIME END TIME
VERY–EARLY-ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD); CLINICAL PRESENTATION, RESPONSE TO THERAPY AND PROGNOSIS. EP11 13:00 13:05 1
CHARACTERISTICS OF VERY EARLY ONSET-INFLAMMTORY  BOWEL DISEASE: A SINGLE CENTER EXPERIENCE USING A PHENOTYPIC CLASSIFICATION EP12 13:05 13:10 2
PHENOTYPIC FEATURES AND LONG-TERM OUTCOMES OF PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS WITH ARTHRITIS AND ARTHRALGIA EP13 13:10 13:15 3
ENTERAL NUTRITION INDUCES CHANGES IN THE FUNCTIONAL REPERTOIRE OF THE HUMAN GUT MICROBIOME EP14 13:15 13:20 4
COLONIC MUCOSAL CYTOKINE PROFILE (CMCP) AFTER REMISSION TREATMENT WITH GRANULOCYTE/MONOCYTE APHERESIS (GMA) IN CHILDREN WITH FIRST ONSET INFLAMMATORY BOWEL COLITIS EP15 13:20 13:25 5
NUDT15 POLYMORPHISMS ARE ASSOCIATED WITH TIME-TO-LEUKOPENIA IN KOREAN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS UNDER TREATMENT WITH THIOPURINES EP16 13:25 13:30 6
SHIFTING THE SHUNTERS IN A PAEDIATRIC INFLAMMATORY BOWEL DISEASE POPULATION (PIBD): THIOPURINE DOSE SPLITTING VERSUS ALLOPURINOL AND THIOPURINE CO-THERAPY EP17 13:30 13:35 7
PREDICTING THIOPURINE-ASSOCIATED ADVERSE EFFECTS IN ASIAN PAEDIATRIC INFLAMMATORY BOWEL DISEASE (PIBD) AND AUTOIMMUNE HEPATITIS PATIENTS WITH NUDT15 MUTATIONS EP18 13:35 13:40 8
MYELOTOXICITY AFTER PRIMOINFECTION WITH EPSTEIN-BARR VIRUS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH THIOPURINES EP19 13:40 13:45 9
ARE DISEASE ACTIVITY, ILLNESS PERCEPTIONS, COPING, ANXIETY, AND DEPRESSION RELATED TO QUALITY OF LIFE IN YOUTH WITH INFLAMMATORY BOWEL DISEASE? EP20 13:45 13:50 10

E-posters 15th Morning – Station 1

TITLE E-POSTER REFERENCE START TIME END TIME
RAPID REVIEW OF RISK STRATIFICATION IN PEDIATRIC CROHN’S DISEASE EP21 13:00 13:05 1
PERINATAL FACTORS AND RISK OF INFLAMMATORY BOWEL DISEASE IN THE OFFSPRING: A SYSTEMATIC REVIEW AND META-ANALYSIS EP22 13:05 13:10 2
COMPARISON OF STOOL BIOMARKERS CALPROTECTIN AND CALGRANULIN C TO SCREEN CHILDREN WITH CHRONIC ABDOMINAL COMPLAINTS FOR ENDOSCOPY. EP23 13:10 13:15 3
FECAL CALPROTECTIN TEST PERFORMED AT HOME – A PROSPECTIVE CLINICAL STUDY IN PIBD EP24 13:15 13:20 4
HEIGHT-Z-SCORE DEFICIT AS A MEASURE OF LINEAR GROWTH IMPAIRMENT IN CHILDREN PRESENTING WITH IBD: A CANADIAN MULTI-CENTRE INCEPTION COHORT STUDY EP25 13:20 13:25 5
BODY MASS INDEX IN THE LOWER OR UPPER QUARTILE IS A MARKER OF SEVERE DISEASE COURSE IN PEDIATRIC IBD PATIENTS. EP26 13:25 13:30 6
SUCCESSFUL USE OF THE IMPROVECARENOW (ICN) QUALITY IMPROVEMENT TOOL: OUR 7 YEAR OUTCOMES AND ACHIEVEMENTS EP27 13:30 13:35 7
COGNITIVE DEBRIEFING INTERVIEWS TOWARDS DEVELOPING A PATIENT REPORTED OUTCOME (PRO) FOR PEDIATRIC ULCERATIVE COLITIS (TUMMY-UC) IN A PHASE 2B STUDY EP28 13:35 13:40 8
PLANNED TRANSITION OF ADOLESCENT IBD PATIENTS FROM PEDIATRIC TO ADULT CARE RESULTS IN HIGHER REMISSION RATES EP29 13:40 13:45 9
SURGERY IN CHILDHOOD-ONSET INFLAMMATORY BOWEL DISEASE 1990-2014 – A NATIONWIDE REGISTER-BASED STUDY IN SWEDEN EP30 13:45 13:50 10
 

E-posters 15th Morning – Station 2

TITLE E-POSTER REFERENCE START TIME END TIME
PREDICTIVE FACTORS OF RESPONSE TO THE EXCLUSIVE ENTERAL NUTRITION IN NEWLY DIAGNOSED CROHN´S DISEASE CHILDREN: PRESENCE STUDY. EP31 13:00 13:05 1
TROUGH LEVELS TO INFLIXIMAB  AT W6 ARE PREDICTIVE OF REMISSION AT W14, IN PEDIATRIC CROHN DISEASE. EP32 13:05 13:10 2
INFLIXIMAB TROUGH LEVELS AND MUCOSAL HEALING ARE ASSOCIATED WITH SUSTAINED CLINICAL REMISSION AFTER INFLIXIMAB CESSATION IN PEDIATRIC CROHN’S DISEASE PATIENTS EP33 13:10 13:15 3
BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE EVALUATION OF THE “QUICK STEP-UP” PROTOCOL EP34 13:15 13:20 4
LONG-TERM OUTCOMES AFTER SWITCHING TO CT-P13 IN PEDIATRIC-ONSET INFLAMMATORY BOWEL DISEASE: A SINGLE-CENTER PROSPECTIVE OBSERVATIONAL STUDY EP35 13:20 13:25 5
MAINTENANCE BIOSIMILAR INFLIXIMAB THERAPY IN CROHN DISEASE PAEDIATRIC PATIENTS AFTER SWITCHING FROM ORIGINAL MOLECULE. EP36 13:25 13:30 6
EFFICACY AND SAFETY OF ADALIMUMAB AFTER INFLIXIMAB FAILURE IN PEDIATRIC ULCERATIVE COLITIS: A REAL-LIFE EXPERIENCE FROM THE SIGENP-IBD REGISTRY EP37 13:30 13:35 7
EFFICACY AND SAFETY OF VEDOLIZUMAB TREATMENT IN PAEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE EP38 13:35 13:40 8
VEDOLIZUMAB THERAPEUTIC DRUG MONITORING MAY PREDICT OUTCOME IN PEDIATRIC IBD (PIBD) EP39 13:40 13:45 9
SUBCUTANEOUS USTEKINUMAB PROVIDED CLINICAL AND BIOLOGICAL BENEFIT FOR 9/12 REFRACTORY PEDIATRIC CROHN’S DISEASE EP40 13:45 13:50 10